Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Oliver A. Cornely(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), D. Angulo-González, Ramachandran Suresh(United States Nuclear Regulatory Commission), David Helfgott(Cornell University), Dick Stockelberg(Sahlgrenska University Hospital), Cathy Hardalo, Thomas J. Walsh(Cornell University), Mario Petrini(University of Pisa), Jerzy Hołowiecki(Medical University of Silesia), Johan Maertens(Unknown), Drew J. Winston(University of California, Los Angeles), Andrew J. Ullmann(University of Würzburg), Yeow-Tee Goh(Singapore General Hospital), John R. Perfect(Duke University)
Cited by 1,806
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k